Skip to main navigation

Home
About Us
Investors
Request Kits
Billing
Forms
Login
00

Investor Relations

Overview
News & Events
SEC Filings
Financial Information
- Quarterly Earnings
- Annual Reports
Stock Information
Leadership
Sustainability
- Our Approach
- Disclosures and Policies
Corporate Governance
- Governance Documents
- Committee Composition
Investor Resources

Quarterly Earnings

Show all

2024

Q1

Q1 2024 Fulgent Genetics Earnings Conference Call

2023

Q4

Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
Q4 2023 Fulgent Genetics Earnings Conference Call
Form 10-K

Q3

Fulgent Reports Third Quarter 2023 Financial Results
Q3 2023 Fulgent Genetics Earnings Conference Call
Form 10-Q

Q2

Fulgent Reports Second Quarter 2023 Financial Results
Q2 2023 Fulgent Genetics Earnings Conference Call
Form 10-Q

Q1

Fulgent Reports First Quarter 2023 Financial Results
Q1 2023 Fulgent Genetics Earnings Conference Call
Form 10-Q

2022

Q4

Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results
Q4 2022 Fulgent Genetics Earnings Conference Call
Form 10-K

Q3

Fulgent Genetics Reports Third Quarter 2022 Financial Results
Q3 2022 Fulgent Genetics Earnings Conference Call
Form 10-Q

Q2

Fulgent Genetics Reports Second Quarter 2022 Financial Results
Q2 2022 Fulgent Genetics Earnings Conference Call
Form 10-Q

Q1

Fulgent Genetics Reports First Quarter 2022 Financial Results
Q1 2022 Fulgent Genetics Earnings Conference Call
Form 10-Q

2021

Q4

Fulgent Genetics Reports Fourth Quarter and Full Year 2021 Financial Results
Q4 2021 Fulgent Genetics Earnings Conference Call
Form 10-K

Q3

Fulgent Genetics Reports Third Quarter Financial Results
Q3 2021 Fulgent Genetics Earnings Conference Call
Form 10-Q

Q2

Fulgent Genetics Reports Second Quarter Financial Results
Q2 2021 Fulgent Genetics Earnings Conference Call
Form 10-Q

Q1

Fulgent Genetics Reports Record First Quarter Financial Results
Q1 2021 Fulgent Genetics Earnings Conference Call
Form 10-Q

2020

Q4

Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results
Q4 2020 Fulgent Genetics Earnings Conference Call
Form 10-K

Printer-friendly Printer-friendly
RSS Feeds RSS Feeds
Email Alerts Email Alerts
View contacts View contacts

Overview
News & Events
SEC Filings
Financial Information
- Quarterly Earnings
- Annual Reports
Stock Information
Leadership
Sustainability
- Our Approach
- Disclosures and Policies
Corporate Governance
- Governance Documents
- Committee Composition
Investor Resources

Address
Fulgent Genetics
4399 Santa Anita Ave,
El Monte, CA 91731

Contact
Phone: +1 (626) 350-0537
Fax: +1 (626) 454-1667
Email: info@fulgentgenetics.com

Products
Genes & Panels
Known Mutation
Genomic Testing
Carrier Screening
Hereditary Cancer
Oncology Services
BioPharma Services

Resources
Billing
Forms & Documents
Request a Kit
Specimen Requirements & Logistics

Company
About Fulgent
Accreditations
Careers

HQ | 4399 Santa Anita Ave., El Monte, CA 91731 P | (+1) 626-350-0537 F | (+1) 626-454-1667
W | www.FulgentGenetics.com E | info@FulgentGenetics.com
CLIA | 05D2043189 CA | CLF 00342581 CAP | 8042697
2018 © Fulgent Genetics. All rights reserved.